阿拉伯语国际体育锻炼问卷测量糖尿病患者中等强度到高强度体育锻炼的有效性

IF 2.8 3区 医学 Q3 ENDOCRINOLOGY & METABOLISM Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Pub Date : 2024-09-17 DOI:10.2147/dmso.s474202
Ebaa Al Ozairi, Husain AlSaraf, Abdullah Al-Ozairi, Yasmine Hamdan, Batool Camille Al Esmaeel, Dalal Alsaeed, Mohamed Abdalla, Stuart R Gray
{"title":"阿拉伯语国际体育锻炼问卷测量糖尿病患者中等强度到高强度体育锻炼的有效性","authors":"Ebaa Al Ozairi, Husain AlSaraf, Abdullah Al-Ozairi, Yasmine Hamdan, Batool Camille Al Esmaeel, Dalal Alsaeed, Mohamed Abdalla, Stuart R Gray","doi":"10.2147/dmso.s474202","DOIUrl":null,"url":null,"abstract":"<strong>Purpose:</strong> The aim of this cross-sectional study was to compare the Arabic version of International Physical Activity Questionnaire (IPAQ) measured moderate-to-vigorous physical activity (MVPA) with accelerometer-measured MVPA in people with diabetes.<br/><strong>Methods:</strong> From 2020 to 2022 physical activity was measured people ≥ 18 years with type 1 or type 2 diabetes in Kuwait. Self-reported MVPA was measured over 7 days with the Arabic version of the IPAQ. During the same 7-day period wrist worn accelerometers were used to objectively measure MVPA. IPAQ MVPA was calculated both including and excluding walking physical activity. MVPA measures were compared by limits of agreement approach, Pearson correlations and concordance correlations.<br/><strong>Results:</strong> We recruited 240 participants with type 1 diabetes and 343 participants with type 2 diabetes for the study. In people with type 1 diabetes, there were no concordance correlations between IPAQ MVPA, both including (rho = − 0.011 (− 0.038, 0.017), p = 0.444) and excluding (rho = − 0.001 (− 0.067, 0.065), p = 0.978) walking physical activity. MVPA measured by IPAQ was 43.3(− 85.6, 172.2) min/day higher than accelerometer-measured MVPA, when including walking, and 8.88(− 60.4, 78.2) min/day higher, when excluding walking. In people with type 2 diabetes, there were significant positive concordance correlations between IPAQ MVPA, both including (rho = 0.038 (0.02, 0.06), p &lt; 0.001) and excluding (rho = 0.34 (0.27, 0.41), p &lt; 0.001) walking physical activity. MVPA measured by IPAQ was 62.3 (95% CI − 61.5 to 186.0) min/day higher than accelerometer-measured MVPA, when including walking, and 4.0 (95% CI − 34.1 to 42.0) min/day higher, when excluding walking.<br/><strong>Conclusion:</strong> In people with type 1 or type 2 diabetes, caution should be exercised when using the Arabic version of the IPAQ to measure MVPA.<br/><br/><strong>Keywords:</strong> metabolic disease, activity, Arab, validation<br/>","PeriodicalId":11116,"journal":{"name":"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy","volume":null,"pages":null},"PeriodicalIF":2.8000,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Validity of the Arabic International Physical Activity Questionnaire to Measure Moderate-to-Vigorous Physical Activity in People with Diabetes\",\"authors\":\"Ebaa Al Ozairi, Husain AlSaraf, Abdullah Al-Ozairi, Yasmine Hamdan, Batool Camille Al Esmaeel, Dalal Alsaeed, Mohamed Abdalla, Stuart R Gray\",\"doi\":\"10.2147/dmso.s474202\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<strong>Purpose:</strong> The aim of this cross-sectional study was to compare the Arabic version of International Physical Activity Questionnaire (IPAQ) measured moderate-to-vigorous physical activity (MVPA) with accelerometer-measured MVPA in people with diabetes.<br/><strong>Methods:</strong> From 2020 to 2022 physical activity was measured people ≥ 18 years with type 1 or type 2 diabetes in Kuwait. Self-reported MVPA was measured over 7 days with the Arabic version of the IPAQ. During the same 7-day period wrist worn accelerometers were used to objectively measure MVPA. IPAQ MVPA was calculated both including and excluding walking physical activity. MVPA measures were compared by limits of agreement approach, Pearson correlations and concordance correlations.<br/><strong>Results:</strong> We recruited 240 participants with type 1 diabetes and 343 participants with type 2 diabetes for the study. In people with type 1 diabetes, there were no concordance correlations between IPAQ MVPA, both including (rho = − 0.011 (− 0.038, 0.017), p = 0.444) and excluding (rho = − 0.001 (− 0.067, 0.065), p = 0.978) walking physical activity. MVPA measured by IPAQ was 43.3(− 85.6, 172.2) min/day higher than accelerometer-measured MVPA, when including walking, and 8.88(− 60.4, 78.2) min/day higher, when excluding walking. In people with type 2 diabetes, there were significant positive concordance correlations between IPAQ MVPA, both including (rho = 0.038 (0.02, 0.06), p &lt; 0.001) and excluding (rho = 0.34 (0.27, 0.41), p &lt; 0.001) walking physical activity. MVPA measured by IPAQ was 62.3 (95% CI − 61.5 to 186.0) min/day higher than accelerometer-measured MVPA, when including walking, and 4.0 (95% CI − 34.1 to 42.0) min/day higher, when excluding walking.<br/><strong>Conclusion:</strong> In people with type 1 or type 2 diabetes, caution should be exercised when using the Arabic version of the IPAQ to measure MVPA.<br/><br/><strong>Keywords:</strong> metabolic disease, activity, Arab, validation<br/>\",\"PeriodicalId\":11116,\"journal\":{\"name\":\"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2024-09-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2147/dmso.s474202\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/dmso.s474202","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

摘要

目的:本横断面研究旨在比较阿拉伯语版国际体力活动问卷(IPAQ)测量的糖尿病患者中强度体力活动(MVPA)与加速度计测量的中强度体力活动:从 2020 年到 2022 年,对科威特≥ 18 岁的 1 型或 2 型糖尿病患者的体力活动进行了测量。使用阿拉伯语版的 IPAQ 对自我报告的 MVPA 进行了为期 7 天的测量。在同一 7 天内,使用腕戴式加速度计对 MVPA 进行客观测量。IPAQ MVPA 的计算包括和不包括步行体力活动。MVPA 测量结果通过一致性极限法、皮尔逊相关性和一致性相关性进行比较:我们招募了 240 名 1 型糖尿病患者和 343 名 2 型糖尿病患者参与研究。在 1 型糖尿病患者中,IPAQ MVPA 与包括步行体力活动(rho = - 0.011 (- 0.038, 0.017),p = 0.444)和不包括步行体力活动(rho = - 0.001 (- 0.067, 0.065),p = 0.978)之间不存在协整相关性。如果包括步行,IPAQ 测量的 MVPA 比加速度计测量的 MVPA 高 43.3(- 85.6,172.2)分钟/天;如果不包括步行,则 MVPA 高 8.88(- 60.4,78.2)分钟/天。在 2 型糖尿病患者中,IPAQ MVPA 与包括步行(rho = 0.038 (0.02, 0.06),p <0.001)和不包括步行(rho = 0.34 (0.27, 0.41),p <0.001)的体力活动之间存在显著的正相关性。在包括步行的情况下,IPAQ测量的MVPA比加速度计测量的MVPA高62.3(95% CI - 61.5至186.0)分钟/天;在不包括步行的情况下,IPAQ测量的MVPA比加速度计测量的MVPA高4.0(95% CI - 34.1至42.0)分钟/天:结论:对于1型或2型糖尿病患者,在使用阿拉伯语版IPAQ测量MVPA时应谨慎。 关键词:代谢性疾病;活动;阿拉伯语;验证
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Validity of the Arabic International Physical Activity Questionnaire to Measure Moderate-to-Vigorous Physical Activity in People with Diabetes
Purpose: The aim of this cross-sectional study was to compare the Arabic version of International Physical Activity Questionnaire (IPAQ) measured moderate-to-vigorous physical activity (MVPA) with accelerometer-measured MVPA in people with diabetes.
Methods: From 2020 to 2022 physical activity was measured people ≥ 18 years with type 1 or type 2 diabetes in Kuwait. Self-reported MVPA was measured over 7 days with the Arabic version of the IPAQ. During the same 7-day period wrist worn accelerometers were used to objectively measure MVPA. IPAQ MVPA was calculated both including and excluding walking physical activity. MVPA measures were compared by limits of agreement approach, Pearson correlations and concordance correlations.
Results: We recruited 240 participants with type 1 diabetes and 343 participants with type 2 diabetes for the study. In people with type 1 diabetes, there were no concordance correlations between IPAQ MVPA, both including (rho = − 0.011 (− 0.038, 0.017), p = 0.444) and excluding (rho = − 0.001 (− 0.067, 0.065), p = 0.978) walking physical activity. MVPA measured by IPAQ was 43.3(− 85.6, 172.2) min/day higher than accelerometer-measured MVPA, when including walking, and 8.88(− 60.4, 78.2) min/day higher, when excluding walking. In people with type 2 diabetes, there were significant positive concordance correlations between IPAQ MVPA, both including (rho = 0.038 (0.02, 0.06), p < 0.001) and excluding (rho = 0.34 (0.27, 0.41), p < 0.001) walking physical activity. MVPA measured by IPAQ was 62.3 (95% CI − 61.5 to 186.0) min/day higher than accelerometer-measured MVPA, when including walking, and 4.0 (95% CI − 34.1 to 42.0) min/day higher, when excluding walking.
Conclusion: In people with type 1 or type 2 diabetes, caution should be exercised when using the Arabic version of the IPAQ to measure MVPA.

Keywords: metabolic disease, activity, Arab, validation
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Pharmacology, Toxicology and Pharmaceutics-Pharmacology
CiteScore
5.90
自引率
6.10%
发文量
431
审稿时长
16 weeks
期刊介绍: An international, peer-reviewed, open access, online journal. The journal is committed to the rapid publication of the latest laboratory and clinical findings in the fields of diabetes, metabolic syndrome and obesity research. Original research, review, case reports, hypothesis formation, expert opinion and commentaries are all considered for publication.
期刊最新文献
Association Between Weight-Adjusted Waist Index and Albuminuria in Type 2 Diabetes Mellitus in the Chinese Population. Techniques for Implementing Continuous Glucose Monitoring in Primary Care: Key CGM Updates and Highlights from the ATTD 2024 Conference [Podcast]. Diagnostic Utility of Triglyceride-Glucose Index in Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study on Lean Population. Initiation of Insulin Degludec in Chinese Hospitalized Patients with Type 2 Diabetes - A Single Center's Experience. Targeting the Epigenetic Marks in Type 2 Diabetes Mellitus: Will Epigenetic Therapy Be a Valuable Adjunct to Pharmacotherapy?
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1